Hannah is a cell biologist with expertise in ageing and longevity research, specifically the role of cellular senescence. She has recently completed an interdisciplinary PhD and Post-Doc at Queen Mary University of London, and has prior experience whilst collaborating with Unilever, with further industry experience working for AstraZeneca. Hannah holds a Bsc from the University of Leicester.